The QT interval and torsade de pointes

Drug Safety

Volumn 21, Issue SUPPL. 1, 1999, Pages 5-10

  Moss, Arthur J ^a,b  

^a UNIVERSITY OF ROCHESTER MEDICAL CENTER   (United States)

^b UNIVERSITY OF ROCHESTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMANTADINE; AMIODARONE; ANTIARRHYTHMIC AGENT; ANTIHISTAMINIC AGENT; ANTIINFECTIVE AGENT; ASTEMIZOLE; BEPRIDIL; CISAPRIDE; CLARITHROMYCIN; COTRIMOXAZOLE; CYTOCHROME P450; DISOPYRAMIDE; EBASTINE; ERYTHROMYCIN; FLUCONAZOLE; IBUTILIDE; ION CHANNEL; ITRACONAZOLE; KETOCONAZOLE; LIDOFLAZINE; LITHIUM; MICONAZOLE; PENTAMIDINE; PRENYLAMINE; PROCAINAMIDE; PSYCHOTROPIC AGENT; QUINIDINE; SOTALOL; TERFENADINE; THIORIDAZINE; TRICYCLIC ANTIDEPRESSANT AGENT;

ADOLESCENT; ADULT; CHILD; CONFERENCE PAPER; ELECTROCARDIOGRAM; FEMALE; HEART MUSCLE; HEART VENTRICLE TACHYCARDIA; HUMAN; LONG QT SYNDROME; MALE; POTASSIUM CURRENT; PRIORITY JOURNAL; QT INTERVAL; TORSADE DES POINTES;

EID: 0033404894     PISSN: 01145916     EISSN: None     Source Type: Journal    
DOI: 10.2165/00002018-199921001-00002     Document Type: Conference Paper

References (17)

1. Sagie A, Larson MG, Goldeberg RJ, et al. An improved method for adjusting the QT interval for heart rate (the Framingham Heart Study). Am J Cardiol 1992; 70: 797-801
2. Bazett HC. An analysis of time relations of electrocardiograms. Heart 1920; 7: 353-67
3. Fridericia LS. Die systolendauer in elektrokardiogramm bei normalen menschen and bei herzkranken. Acta Med Scand 1920; 53: 469-86
4. Shipley RA, Hallaran WR. Four-lead electrocardiogram in 200 normal men and women. Am Heart J 1936; 11: 325-45
5. Goldman MJ. Principles of clinical electrocardiography. 8th ed. Los Altos, CA: Lange Medical Publications, 1973: 24-8
6. Lepeschkin E. Modern electrocardiography. Vol. 1. Baltimore: William & Wilkins, 1951
7. Moss AJ. Measurement of the QT interval and the risk associated with QT interval prolongation: a review. Am J Cardiol 1993; 72: 21-3B
8. Moss AJ, Robinson JL. The long-QT syndrome: genetic considerations. Trends Cardiovasc Med 1992; 2: 81-3
9. Roden DM, Lazzara R, Rosen M, et al. for the SADS Foundation Task Force on LQTS. Multiple mechanisms in the long-QT syndrome: current knowledge, gaps, and future directions. Circulation 1996; 94: 1996-2012
10. Wang Q, Curran ME, Splawski I, et al. Positional cloning of a novel potassium channel gene: KVLQTI mutations cause cardiac arrhythmias. Nat Genet 1996; 12: 17-23
11. Ks potassium channel. Nature 1996; 384: 80-83
12. Curran ME, Splawski I, Timothy K, et al. A molecular basis for cardiac arrhythmia: HERG mutations cause long QT syndrome. Cell 1995; 80: 795-803
13. Kr. Nature 1997; 388: 289-92
14. Wang Q, Shen J, Splawski I, et al. SCN5A mutations cause an inherited cardiac arrhythmia, long QT syndrome. Cell 1995; 80: 805-11
15. Sicouri S, Antzelevitch C. A subpopulation of cells with unique electrophysiological properties in the deep subepicardium of the canine ventricle: the M cell. Cire Res 1991; 68: 1729-41
16. Dessertenne F. La tachycardic ventriculaire a deux loyers opposes variables. Arch Mal Cocur 1966; 59: 263-72
17. Honig PK, Wortham DC, Zumani K, et al. Terfenadine-ketoconazole interaction: pharmacokinetic and electrocardiographic consequences, JAMA 1993; 269: 1513-8